Table 1: Comparative baseline characteristics of the study cohort at JUSH, February 10 - March 10, 2015.

All n=280 TDF group
(n=140)
AZT group
(n=140)
p-value
Variables
Sex
  Male
 Female

50(35.7)
90(64.3)

47(33.6)
93(66.4)

0.706
Age
 <25
 26-45
 >45

27(19.3)
108(77.1)
5(3.6)

32(25.9)
98(85.9)
10(7.2)

0.196
BMI
  <18.5
 >18.5

52(37.1)
88(62.9)

37(26.4)
93(73.6)

0.075
Educational level
 Illiterate
 Primary
 Post-primary

22(15.8)
48(34.2)
70(50)

30(21.4)
58(41.4)
52(37.2)

0.089
Residence
  Urban
 Rural

97(69.3)
43(30.7)

110(78.5)
30(21.5)

0.13
Occupation
  Employed
 Unemployed
 Housewife

68(48.6)
46(22.8)
26(18.6)

58(41.5)
55(39.2)
27(19.3)

0.296
Religion
  Orthodox
 Muslim
 Others

59(42.1)
45(32.1)
36(25.8)

80(57.1)
42(30)
18(12.9)

0.01
Marital status
 Single
 Married
 Divorced
 Widowed

76(54.3)
23(16.5)
33(23.5)
8(5.7)

77(55.0)
29(20.7)
21(15.1)
13(9.2)

0.207
Alcohol
 No
 Yes

113(80.7)
27(19.3)

102(72.9)
38(27.1)

0.119
BaselineCD4+count
 (Mean + SD)
 <200
  >200

164.64 + 83.36
92(65.7)
48(34.3)

175.21 + 89.14
74(53.9)
66(47.1)

0.029
WHO stage
 I
 II
 III
 IV

32(22.9)
46(32.9)
47(33.6)
15(10.6)

36(25.7)
47(33.6)
43(30.7)
14(10)

0.928
Functional status
 W
  A
 B

110(78.6)
24(17.1)
6(4.3)

79(56.4)
56(40.0)
5(3.6)

0.000
TB(treatment)
 No
 Yes

120(84.7)
20(15.3)

113(87.9)
17(12.1)

0.597
Prophylaxis
 CPT+ INH
 CPT alone
  Neither

37(26.4)
86(61.4)
17(12.2)

30(21.5)
99(70.7)
11(7.8)

0.231

BMI-body mass index, OIs-opportunistic infections, CPT-cotrimoxazole, INH-Isoniazid, TB-Tuberculosis, TDF-Tenofovir, AZT-Zidovudine, WHO-World health organization, CD4-cluster of differentiation, SD-Standard deviation